
Dry Eye
Latest News
CME Content




A new therapy is being investigated in a phase IIb trial to test its safety and effectiveness in patients with moderate-to-severe dry eye disease.


In our latest episode, Laura M. Periman, MD, shares her experience using intense pulsed light (IPL) therapy, and the benefits she's found in it for treating patients with chalazion.

Supplementation no better than placebo as results confirm previous research

Harvey A. Fishman, MD, PhD, shares why intense pulsed light (IPL) therapy is a valuable asset in any ophthalmologist's toolbox

Poor eyelid performance while sleeping a common contributing factor

Centuries of research show treating deficiencies can have dramatic impact


Here's why John Sheppard, MD, believes nutrition should be the cornerstone of dry eye therapy.

When used in supplement with other dry eye treatments, patients see improvement

Topical drug for the treatment of dry eye disease sees potential

Laura M. Periman, MD, shares how IPL therapy can quickly rid patients of painful chalazions

Stephen C. Pflugfelder, MD, honored as the recipient of the Binkhorst Lecture and medal at ASCRS 2019, lectured on the quest for tear stability in dry eye patients.

Many medical specialties share medications and technologies, from various classes of drugs to diagnostic testing and surgical instruments. Here are just a few “adopted” technologies we’re happy to see in the hands of ophthalmologists.

Thermal pulsation therapy has potential to improve gland structure in most patients.

Start ocular surface treatment 6 weeks prior to cataract surgery for best outcomes

Study and use of platelet preparation, other biologics viewed as next frontier

BRM421 safe, well tolerated in controlled adverse environment model

First treat pre-existing conditions, such as medication toxicity, eyelid disease

Phase II proof-of-concept study indicates efficacy signals at day 28 and day 84

New diagnostic modalities have enhanced clinical abilities, whereas some standbys still get the job done

Management evolves from nasal neurostimulation, prosthetic replacement of ocular surface ecosystem




















































.png)


